Trial Profile
Incident Type II Diabetes Mellitus Among Patients Exposed to the Combination of Pravastatin and Paroxetine
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Paroxetine (Primary) ; Pravastatin (Primary)
- Indications Cardiovascular disorders; Depressive disorders
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 01 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 24 May 2012 New trial record